Important insights into the mechanisms behind Fuchs endothelial corneal dystrophy (FECD), a common cause of age-related visual loss, have been revealed in a new study led by UCL researchers.

Approximately 4% of people aged 40 years and older have corneal endothelial disease/dystrophy (CED) affecting the back of the cornea, and corneal transplantation is the only treatment option for ...

The mechanism of the inherited retinal dystrophies. Age-dependent corneal endothelial dystrophy. Council Member, The Society of Experimental Biology and Medicine Membership Committee Member, The ...

In this Healio Video Perspective from Hawaiian Eye 2025, Greg Kunst, CEO of Aurion Biotech, discusses positive phase 1/2 data for the company’s cell therapy for corneal endothelial disease.

It tested dose levels of 150,000, 500,000 and one million endothelial cells in ... for conditions like Fuchs dystrophy.“ An estimated 50,000 corneal transplants are currently performed each ...

Contraindications: iDose TR is contraindicated in patients with active or suspected ocular or periocular infections, patients with corneal endothelial cell dystrophy (e.g., Fuch’s Dystrophy ...

Her laboratory is responsible for identification of genes for many different diseases, most recently for Age-Related Macular Degeneration (AMD) and Fuchs’ Endothelial Corneal Dystrophy (FECD). Her ...